M. Bannink

Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen

Lisette Binkhorst, Ron H.J. Mathijssen, Myrthe P. P. van Herk‐Sukel et al. · Breast Cancer Research and Treatment · 2013 · 68 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients

Arthur R. Van Gool, Durk Fekkes, Wim H.J. Kruit et al. · Psychiatry Research · 2003 · 41 citations

Medicine, Immunology, Oncology +15

Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch

Lisette Binkhorst, M. Bannink, Peter de Bruijn et al. · Clinical Pharmacokinetics · 2015 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Changes in and correlates of individual quality of life in advanced cancer patients admitted to an academic unit for palliative care

Michael A. Echteld, Lia van Zuylen, M. Bannink et al. · Palliative Medicine · 2007 · 26 citations

Medicine, Oncology, Functional Assessment +14

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon‐α: Course and relationship with psychiatric status

Arthur R. Van Gool, Robert Verkerk, Durk Fekkes et al. · Psychiatry and Clinical Neurosciences · 2008 · 25 citations

Medicine, Pharmacology, Psychiatry +15